Literature DB >> 19932027

alpha-Glucosidase inhibitory antihyperglycemic activity of substituted chromenone derivatives.

B China Raju1, Ashok K Tiwari, J Ashok Kumar, A Zehra Ali, Sachin B Agawane, G Saidachary, K Madhusudana.   

Abstract

Series of 3,4- and 3,6-disubstituted chromenones including new chromenone derivatives were synthesized applying various synthetic strategies including Pechmann condensation, Knoevenagel condensation, Reimer-Tiemann reaction and Suzuki coupling in very good yields. Synthesized compounds (4a-z) were screened for in vitro alpha-glucosidase inhibitory and 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging activities. Majority of compounds displayed varying degrees of alpha-glucosidase inhibitory and DPPH scavenging activity. Compound 4x emerged as the most potent alpha-glucosidase inhibitor in present series of compounds owing to the presence of 3-acetyl-6-(6-methoxy-3-pyridyl) group on chromenone; however, it could not display DPPH scavenging activity and was found to be mixed non-competitive type inhibitor of rat intestinal alpha-glucosidase. When tested in vivo for antihyperglycemic activity in starch loaded Wistar rats, it displayed significant antihyperglycemic property. This is the first report assigning rat intestinal alpha-glucosidase inhibitory property for this class of new chromenones and presents new family of compounds possessing alpha-glucosidase inhibitory activities and antihyperglycemic property. Compound 4x may serve as an interesting new compound for the development of therapeutics targeted against diet-induced hyperglycemia in diabetes. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932027     DOI: 10.1016/j.bmc.2009.10.047

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  Fe3O4@C@OSO3H as an efficient, recyclable magnetic nanocatalyst in Pechmann condensation: green synthesis, characterization, and theoretical study.

Authors:  Zahra Samiei; Somayeh Soleimani-Amiri; Zahra Azizi
Journal:  Mol Divers       Date:  2020-01-11       Impact factor: 2.943

2.  FNF-12, a novel benzylidene-chromanone derivative, attenuates inflammatory response in in vitro and in vivo asthma models mediated by M2-related Th2 cytokines via MAPK and NF-kB signaling.

Authors:  Mohammad Abohassan; Mesfer Al Shahrani; Mohammad Y Alshahrani; Naseem Begum; Suresh Radhakrishnan; Prasanna Rajagopalan
Journal:  Pharmacol Rep       Date:  2021-09-01       Impact factor: 3.024

3.  Bio-Oriented Synthesis of Novel (S)-Flurbiprofen Clubbed Hydrazone Schiff's Bases for Diabetic Management: In Vitro and In Silico Studies.

Authors:  Aftab Alam; Mumtaz Ali; Najeeb Ur Rehman; Saeed Ullah; Sobia Ahsan Halim; Abdul Latif; Ajmal Khan; Obaid Ullah; Shujaat Ahmad; Ahmed Al-Harrasi; Manzoor Ahmad
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-27

4.  Evaluation of halogenated coumarins for antimosquito properties.

Authors:  Venugopala K Narayanaswamy; Raquel M Gleiser; Kabange Kasumbwe; Bandar E Aldhubiab; Mahesh V Attimarad; Bharti Odhav
Journal:  ScientificWorldJournal       Date:  2014-12-25

5.  Study on preparation of chickpea peptide and its effect on blood glucose.

Authors:  Xuemei Ma; Xing Fan; Deping Wang; Xianai Li; Xiaoyun Wang; Jiangyong Yang; Chenggong Qiu; Xiaolu Liu; Guangxian Pang; Redili Abra; Liang Wang
Journal:  Front Nutr       Date:  2022-09-16

6.  3-(4-Meth-oxy-benzo-yl)-6-nitro-coumarin.

Authors:  Saleta Vazquez-Rodriguez; Eugenio Uriarte; Lourdes Santana
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-02-06

Review 7.  Chromanone-A Prerogative Therapeutic Scaffold: An Overview.

Authors:  Sonia Kamboj; Randhir Singh
Journal:  Arab J Sci Eng       Date:  2021-06-30       Impact factor: 2.807

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.